CURRICULUM VITAE

Gary Evan Lemack, M.D. PERSONAL ADDRESS

5705 River Rock Lane Plano, TX 75093 (972) 378-5128

OFFICE ADDRESS

Room JA5.130D Department of Urology UT Southwestern Medical Center 5323 Harry Hines Blvd. Dallas, TX 75390-9110 Office: (214) 648-7190

E-MAIL ADDRESS

[email protected]

BIRTHDATE

October 9, 1965

FAMILY

Wife, Abbe, former assistant director of surgical services at Beth Israel Hospital, North Division, New York, New York Daughter, Ilana Morgan, born April 1, 1997 Son, Bergen Elliot, born May 16, 1999 Daughter, Devyn Jill, born August 21, 2001

EDUCATION

Cornell University, Ithaca, New York B.A., Biology (Concentration - Anatomy and Physiology) September, 1983 - June, 1987 Cornell University Medical College M.D., September, 1987 - May, 1991

SURGICAL TRAINING

The New York Hospital - Cornell Medical Center July, 1991 - June 1993

UROLOGICAL TRAINING RESIDENCY

The New York Hospital - Cornell Medical Center Program Director, E. Darracott Vaughan, Jr., M.D. July, 1993 - June, 1997

Last Revised: April 9, 2015

FELLOWSHIP

University of Texas Southwestern Medical Center Basic science research, physiology of bladder obstruction. Program Director, John D. McConnell, M.D. July 1997 - June, 1998. University of Texas Southwestern Medical Center Clinical Fellowship in female and reconstructive urology. Fellowship director, Philippe Zimmern, M.D. July 1998 - June 1999.

PROFESSIONAL

Residency Program Director, Department of Urology, UT Southwestern Medical Center

.

Fellowship Director, Female Pelvic Medicine and Reconstructive Surgery, Urology, UT Southwestern Medical Center Professor of Urology and Neurology, Director of Neurourology, Department of Urology, UT Southwestern Medical Center

APPOINTMENTS

Attending Medical Staff, Clements University Hospital, Dallas TX Attending Medical Staff and Director of Center for Incontinence and Voiding Dysfunction, Parkland Memorial Hospital, Dallas, TX Attending Medical Staff, Surgical Services, Veterans Affairs Texas Health Care System, Dallas, TX

HONORS/AWARDS UNDERGRADUATE

Phi Beta Kappa, Cornell University Graduate with Distinction in all Subjects Arts and Sciences Dean’s List Fall, 1983 through Fall, 1986

MEDICAL SCHOOL

NIH Research Fellowship, summer 1988 Papanicolaou Fellow in Anatomy, 1990 President Class of 1991, 1990-1991 Graduation Speaker, May 1991

RESIDENCY

AUA-Circon ACMI Essay contest, First Prize for Laboratory Research, “Expression of rat tropoelastin in the transgenic mouse bladder: histologic and physiologic effects,” Annual Meeting of the American Urological Association, May 1996. Best Poster Gallery, “Expression of rat tropoelastin in the transgenic mouse bladder: histologic and physiologic effects.” Annual Meeting of the American Urological Association May 1996.

FELLOWSHIP

Ferdinand C. Valentine Fellowship for basic research in urology, awarded by the New York Academy of Medicine, 1997-1998.

Last Revised: April 9, 2015

FACULTY

MEMBERSHIPS/ CERTIFICATIONS

Named to “Best Doctors in Dallas 2006, 2012, 2014” by peers in D Magazine Top 10 Reviewer, Neurourology and Urodynamics, 2007-8 Honorable Mention for Top Reviewer, Urodynamics/Female Urology/Incontinence, Journal of Urology, 2007 Outstanding Reviewer of the Year, Urodynamics/Female Urology/Incontinence, Journal of Urology, 2008 Distinguished Service Award, for outstanding contributions to Urodynamics, Female Urology, and Voiding Dysfunction and exemplary service to the society, Society for Urodynamics and Female Urology, 2009 Best Poster, “Assessing Urological Needs in Eastern Africa: Founding a Partnership with AMREF,” AUA 2009. Paul M. Zimskind Award, for continuing excellence and leadership in the field of voiding dysfunction, awarded by the Society of Urodynamics and Female Urology, 2011.

Board Certified, American Board of Urology, March, 2001 Board Certified, Female Pelvic Medicine and Reconstruction, 2013 American Urological Association South Central Section of AUA Society for Urodynamics and Female Urology International Continence Society New York State License, inactive Texas State License, active Texas Medical Association Dallas County Medical Society Society of University Urologists Society of Urologic Chairpersons and Program Directors

ACTIVE CLINICAL TRIALS Urological Database with Patients with Neurovesical Dysfunction (CR00001031) Surgical trends for intervention of pelvic organ prolapse and SUI (102014-031) A randomized, double-blind, vehicle controlled dose confirmation, multicenter safety and efficacy study of a single intraprostatic treatment of PRX302 for LUTS in BPH (032013-046) Sophiris BioCorp SP tube QOL in neurogenic bladder patients with SPT (072013-029)

GRANT SUPPORT

Last Revised: April 9, 2015

JOURNAL RESPONSIBILITIES 2015-present, Ad Hoc reviewer, JAMA 2010-present, Editorial Board, Journal of Urology 1999-present, expert reviewer Urology 1999-present, expert reviewer Journal of Urology 2002-present, expert reviewer BJU International 2003-present, expert reviewer European Urology 2003-present, expert reviewer Neurourology and Urodynamics 2001-present, Ad Hoc reviewer, Archives of Neurology 2003-2005, Section editor, Current Urology Reports

UNIVERSITY SERVICE Member, Faculty Senate, 1999-2002 Medical School interviewer, 2000-2005 Medical Executive Council, Zale-Lipshy University Hospital, 20022003, 2005-2006 Medical Directors Clinical Operations Committee, 2003-2004 Best Practices Committee, Zale-Lipshy University Hospital, 20072009 Member, UTSW GME Subcommittee Changes and Additions in Programs Committee, 2011-2014. Member, UTSW GME Duty Hours Subcommittee, 2012 – present UTSW Urology Specialty Faculty Advisor to Medical Student Class, 2009 - present

SPECIALTY/COMMITTEE APPOINTMENTS Executive committee, Member-at-large (2004-6), Chairman of Practice Standards and Parameters Committee (2007-9), Chairman of Residency Education Committee (2010-2012), Secretary/Treasurer (2012-2014), Vice President SUFU (2014 – present), Society for Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction (SUFU) Member, Examination Committee, American Board of Urology, 2006-2011 Editor, Examination Committee, American Board of Urology, 2012-present Member, AUA Annual Meeting Program Planning Committee, 2009-2011 South Central Section of AUA, Board of Directors, 2010-present Urodynamics Guidelines Panel AUA-SUFU, 2009-2012 Oral Examiner, American Board of Urology, 2012-present Board of Directors, Society of Urology Chairpersons and Program Directors (SUCPD), 2012present

Last Revised: April 9, 2015

Chairman, Membership Committee, Society of University Urologists, 2014 – present Vice Chairman, SUFU-AUA SUI Guidelines Panel, 2015 – present Member, EAU Urinary Incontinence Guidelines Panel, 2015 - present

POST-GRADUATE COURSES GIVEN “Introduction to Neurourology”, American Academy of Neurology, April 2002, April 2003 Elliot Frohman, Course Director “Neurotoxin and Desensitization Therapies for Voiding Dysfunction”, American Urological Association, 2005-2011, Raymond Rackley MD, Course Director “Diagnostic approaches to overactive bladder” Post graduate course at International Continence Society annual meeting, October 2003, Florence Italy.

VISITING PROFESSORSHIPS McGill University, 2003 University of Toronto, 2006 University of Iowa, 2008 Vanderbilt University, 2009 Washington University, 2009 University of Michigan, 2012 Virginia Commonwealth University, 2012 Louisiana State University, 2012 Paulista Congress of Urology Sau Paulo Brazil, 2013 University of California at San Diego, 2013 Johns Hopkins University, 2013 New York University, 2013 Urological Association of Australia and New Zealand, 2014 Asociacion de Medicos Urologos Costarricenses, 2014 University of Toledo, 2015 Brown University, 2015

PUBLISHED ABSTRACTS 1. Lemack, G.E., Goldstein, M.: Presence of sperm in the pre-vasectomy reversal semen analysis: Incidence and implications. Poster presentation at American Urological Association Annual Meeting, April, 1995, Las Vegas, NV. 2. Lemack, G.E., Poppas, D.P., Mininberg, D.T.: Laparoscopic treatment of the intraabdominal testis. Podium presentation at American Academy of Pediatrics, Urology Section Annual Meeting, October, 1995, San Francisco, CA. 3. Lemack, G.E., Szabo, Z., Boyd, C., Vaughan, E.D., Jr., Felsen, D.: Expression of rat tropoelastin in transgenic mouse bladder: physiologic and histologic effects. Poster

Last Revised: April 9, 2015

presentations at Gordon Elastin Scientific Symposium, July, 1995, New Hampshire and American Urological Association Annual Meeting, May, 1996, Orlando, FL 4. Lemack, G.E., Goldstein, M.: Antisperm antibodies after reconstructive microsurgery: A retrospective analysis of trends in vasectomized men. Poster presentation at American Society for Reproductive Medicine Annual Meeting, October 1996, Boston, MA. 5. Lemack, G.E., Uzzo, R.G., Schlegel, P.N., Goldstein, M.: Microsurgical repair of the pediatric and adolescent varicocele. Poster presentation at American Urological Association annual meeting, April 1997, New Orleans, LA. 6. Uzzo, R.G., Lemack, G.E., Morrissey, K.P., Goldstein, M.: Effects of mesh bioprosthesis on spermatic cord structures in the dog. Poster presentation at American Urological Association annual meeting, April 1997, New Orleans, LA. 7. Lin, V.K., Boetticher, N.C., Lemack, G.E., Word, R.A., McConnell, J.D.: Expression of SM22 alpha in human prostate. Poster presentation, American Urological Association annual meeting, June 1998, San Diego, CA.  8. Lemack, G.E., Zimmern, P.E., Word, R.A., McConnell, J.D., Lin, V.K.: Enhanced expression of iNOS after partial outlet obstruction in murine bladder: physiologic implications. Poster presentation, American Urological Association annual meeting, June 1998, San Diego, CA. 9. Daneshgari, F., Lemack, G.E., Wyne, K.L., McGarry, D.: A new genetic rat model of diabetes mellitus for studies of lower urinary tract dysfunction. Poster presentation, American Urological Association annual meeting, May 1999, Dallas, TX. 10. Banerjee, A., Daneshgari, F., Gamboni-Robertson, F., Wyne, K., Lemack, G.E., McGarry, J.D.: Alterations in the profile and translocation of protein kinase C in normal and diabetic detrusor muscle of the rat. Poster presentation, American Urological Association annual meeting, May 1999, Dallas, TX. 11. Daneshgari, F., Lemack, G.E., Jacomides, L., Ridlehuber, C., Zimmern, C.: The effects of vaginal packing on urodynamic studies of patients with large cystocele and/or vault prolapse. Poster presentation, American Urological Association annual meeting, May 1999, Dallas, TX. 12. Lemack, G.E., Zimmern, P.E., Foster, B.: Relationship between urogenital distress inventory-6 questionnaire and urodynamic findings. Poster presentation, American Urological Association annual meeting, May 1999, Dallas, TX. 13. Lin, V.K., McConnell, J.D., Lemack, G.E.: Altered response to partial infravesical obstruction in mice lacking inducible nitric oxide synthase. Poster presentation, American Urological Association annual meeting, May 1999, Dallas, TX. 14. Lemack, G.E., Zimmern, P.E., Foster, B.: Predictability of urodynamic findings based on urogenital distress inventory-6 questionnaire. Podium presentation at Urodynamic Society annual meeting, May 1999, Dallas, TX.

Last Revised: April 9, 2015

15. Lemack, G.E., Zimmern, P.E.: Urethral dilation in women: a questionnaire-based analysis of practice patterns. Poster presentation at Urodynamic Society annual meeting, May 1999, Dallas, TX. 16. Zimmern, P., Lemack, G., Blander, D.: Vaginal vault fixation and prevention of enterocele recurrence by high midline levator myorraphy: physical examination and questionnaire base mid-term follow-up. Poster presentation, European Association of Urology annual meeting, April 2000 Brussels, Belgium. 17. Lemack, G.E., Zimmern P.E., Foster, B., Bernier, P., Daneshgari, F.: Are there cause-specific cut-off values for defining bladder outlet obstruction in women? Podium presentation, European Association of Urology annual meeting, April 2000 Brussels, Belgium. 18. Blander, D.S., Lemack, G.E., Zimmern, P.E.: Urodynamic-based outcome for transvaginal urethrolysis. Poster presentation at American Urological Association annual meeting May, 2000, Atlanta, GA. 19. Weber, A.M., Taylor, R., Wei, J.T., Lemack, G.E., Piedmonte, M.R., Walters, M.D.: Cost-effectiveness of preoperative testing for stress urinary incontinence in women. Podium presentation at American Urological Association annual meeting May, 2000, Atlanta, GA. 20. Lemack, G.E., Zimmern, P.E.: Questionnaire-based outcome after anterior vaginal wall suspension for stress urinary incontinence. Poster presentation at American Urological Association annual meeting May, 2000, Atlanta, GA. 21. Dewey, R., Lemack, G.E., O’Suilleabhain, P., Zimmern, P.E.: High incidence of lower urinary tract symptoms (LUTS) in patients with early stage Parkinson’s disease. Poster presentation at American Urological Association annual meeting May, 2000, Atlanta, GA. 22. Lemack, G.E., Zimmern, P.E.: Sexual function after vaginal surgery for stress incontinence: results of a mailed questionnaire. Poster presentation at Urodynamic Society annual meeting, Atlanta, GA, April, 2000. 23. Zimmern, P.E., Lemack, G.E., Moore, S., Martin, B.: Cost effectiveness of a critical care pathway for vaginal surgery. Poster presentation at the European Association of Urology annual meeting, April 2001, Geneva, Switzerland 24. Baseman, A.G., Lemack, G.E., Baseman, J.G., Zimmern, P.E.: Effects of a 6 French urethral catheter on flow rates during repeated pressure flow studies in healthy female volunteers. Journal of Urology 165: 1232, 2001. 25. Lemack, G.E., Baseman, A.G., Zimmern, P.E.: Urodynamic studies in asymptomatic women: Intra-test and Inter-test reproducibility. Journal of Urology 165: 1225, 2001. 26. Lemack, G.E., Dmochowski, R.R., Wilson, T.S., Margulis, V.: Difficulties associated with use of the Urolume prosthesis: lessons learned. Journal of Urology 165: 1144, 2001.

Last Revised: April 9, 2015

27. Baseman, A.G., Lemack, G.E.: Effects of a 6 french urethral catheter on repeated pressure flow studies in healthy female volunteers. Podium presentation at South Central section of AUA, September 2001, Austin, TX. 28. Lorenzo A.J., Wilson T.S., Vazquez, D.J., Lemack, G.E., Lin, V.K., Baker, L.: FKBP65 mRNA expression in the developing mouse bladder. Journal of Urology 167: 991, 2002. 29. Wilson, T.S., Tang J, Wang, S-Y, Lemack, G.E., Lin, V.K.: Acute alterations in both detrusor smooth muscle and extracellular matrix gene expression following spinal cord injury in the mouse. Journal of Urology 167: 1080, 2002. 30. Lemack, G.E., Wilson, T.S., Lin, V.K.: Bladder dysfunction in a murine model of spinal cord injury. Journal of Urology 167:1083, 2002. 31. Lorenzo, A., Zimmern P., Lemack, G., Nurenberg, P.: Endo-rectal coil MRI for diagnosis of urethral and peri-urethral pathology in women. Poster presentation at 18th Congress of the European Association of Urology, Madrid, Spain, March 2003. 32. Lorenzo A.J., Lemack G.E., Abdel-Aziz K., Baker L.A., Role of FK binding protein-65 in the acute response of the bladder to spinal cord injury. Journal of Urology 169: 1387, 2003. 33. Defreitas G.A., Lemack, G.E., Zimmern P.E., Roehrborn C.G., Dewey R.B.: A urodynamic comparison of patients with Parkinson’s Disease and males with lower urinary tract symptoms: distinguishing neurogenic from non-neurogenic detrusor overactivity. Journal of Urology 169: 1506, 2003. 34. Defreitas G.A., Zimmern, P.E., Lemack, G.E., Shariat S.: Refining the diagnosis of female outlet obstruction: a comparison of pressure-flow study parameters in clinically obstructed women to those of normal controls. Poster presentation at Society for Urodynamics and Female Urology, Phoenix AZ, February 2004. 35. Abdel Aziz, K.A., Lemack, G.E., Ramnarayan, P: An Assessment Of Detrusor Contractility Following Spinal Cord Injury In Murine Model. Poster presentation at Societe Internationale d’Urologie, Honolulu HI, August 2004. 36. Lemack, G.E., Ramnarayan P, Zimmern, P.E.: In vitro contractile properties of anterior vaginal wall in postmenopausal women. Poster presentation at International Continence Society, Montreal Canada, August 2005. 37. Lemack, G.E., Zimmern P.E., Frohman E., Hawker K., Ramnarayan P.: Neurogenic versus idiopathic detrusor overactivity: potential ramifications of urodynamic distinctions. Poster presentation at International Continence Society, Montreal Canada, August 2005. 38. Lemack, G.E., Brubaker, L, Nager C, Sirls L, Chai T, Moalli, Kraus S, Kerr L, Xu Y for the Urinary Incontinence Treatment Network: Demographic and Urodynamic Baseline Predictors of Valsalva Leak Point Pressure. Poster presentation at AUA, Atlanta 2006. 39. Lemack, G.E., Ramnarayan P, Frohman E.: Impact of a closed bladder neck on neurogenic detrusor overactivity. Poster presentation at AUA, Atlanta GA, May 2006

Last Revised: April 9, 2015

40. Lemack, G.E.: Impact of diabetes on urodynamic findings among women with stress urinary incontinence. Podium presentation at SCS section of AUA, September 2007. 41. Lemack, G.E., Kennelly, M., Foote, J.: Effect of transdermal oxybutynin on urodynamics in patients with traumatic spinal cord injury. Podium presentation at SCS section of AUA, September 2007. 42. Lemack, G.E., Krauss S., Littman H., Fitzgerald M., Chai, T., Nager C., Sirls L., Zyczynski H., Baker J., Lloyd K., Steers W., for the UITN. Preoperative urodynamic testing does not predict postoperative voiding dysfunction among women undergoing surgery for SUI: results from a prospective randomized trial comparing Burch versus pubovaginal sling. Poster presentation at SUFU, February 2008 43. Fletcher S., Gilchrist A., Frohman, E., Lemack G.E.: Patients with multiple sclerosis and neurovesical dysfunction are at extremely low risk for upper tract deterioration. Podium presentation at SUFU, February 2008 44. Fletcher S., Gilchrist A., Frohman E., Lemack G.E.: Patients with multiple sclerosis and neurovesical dysfunction are at extremely low risk for upper tract deterioration. . Moderated poster session (Abstract 1026), AUA Annual Meeting, Orlando, Florida, May 2008. 45. Fletcher S., Gilchrist A.., Zimmern P.E., Lemack G.E.: Urodynamic factors associated with detrusor overactivity (DO) in women with anterior vaginal wall prolapse – Is bladder outlet obstruction the culprit? Podium presentation (Abstract 1302), AUA Annual Meeting, Orlando, Florida, May 2008. 46. Lemack G.E., Kraus S.R., Litman J.H., FitzGerald M.P., Chai T.C., Nager C.W., Sirls L., Zyczynski H., Baker J., Lloyd L.K., Steers W.: Preoperative urodynamic testing does not predict postoperative voiding dysfunction after surgery for stress urinary incontinence: Results from a prospective randomized surgical trial. Moderated poster presentation (Abstract 1525), AUA Annual Meeting, Orlando, Florida, May 2008. 47. Kraus S.R., Lemack G.E., Brubaker L., Chai T.C., Albo M.E., Litman H.J., Leng W., Sirls L., Lloyd L.K., Norton P.,: Urodynamic changes associated with successful stress urinary incontinence surgery: A little tension is a good thing? Moderated poster presentation (Abstract 1526), AUA Annual Meeting, Orlando, Florida, May 2008. 48. Kraus S.R., Lemack G.E., Chai T.C., Richter H., Albo M.E., Brubaker L., Sirls L., Litman H.J., Norton P., Leng W.: Urodynamic changes 24 months after Burch colposuspension and autologous fascia pubovaginal sling. Moderated podium presentation (Abstract 1527), AUA Annual Meeting, Orlando, Florida, May 2008. 49. Fletcher S.G., Gilchrist A.S., Ruddell T., Lemack G.E.: High grade outlet obstruction is associated with the severity, but not prevalence, of overactive detrusor contractions in men with lower urinary tract symptoms. Moderate poster presentation (Abstract 1532), AUA Annual Meeting, Orlando, Florida, May 2008.

Last Revised: April 9, 2015

50. Haverkorn R, Fletcher S, Lemack GE. Evaluating women with MS and neurovesical dysfunction: is urodynamic testing always necessary? Society for Urodynamics and Female Urology, Las Vegas. February 27, 2009. 51. Fletcher S, Haverkorn R, Lee J, Gupta A, Zimmern P, Lemack GE. Urodynamic abnormalities do not correlate with overall UDI-6 scores among women with anterior vaginal prolapse. Society for Urodynamics and Female Urology, Las Vegas. February 27, 2009. 52. Fletcher S, Haverkorn R, Lal A, Gupta A, Zimmern P, Lemack GE. Regardless of pre-operative urodynamic findings, improvement in LUTS is seen following anterior vaginal prolapse repair. Society for Urodynamics and Female Urology, Las Vegas. February 27, 2009. 53. Lemack, GE, Ellsworth P, Davis R, Wachira J, Oefelein M. Assessing Urological Needs in Eastern Africa: Founding a Partnership with AMREF. Poster presentation at AUA Meeting, April 2009. 54. Fletcher SG, Haverkorn R, Lee A, Gupta A, Zimmern PE, Lemack GE. Demographic and Urodynamic parameters associated with persistent LUTS after prolapse repair. Podium presentation at AUA Meeting, April 2009. 55. Hall SH, Curto TM, Onyenwenyi A, Lemack GE, Tennstedt SL, Link CL, McKinlay JB. Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the Boston Area Community Health (BACH) Survey. Poster presentation at American Academy of Neurology. 2011. 56. Murray S, Dillon BE, Haverkorn RM, and Lemack GE: Prevalence of upper tract abnormalities in a contemporary series of spinal cord injured patients. Poster presentation at AUA annual meeting, May 2011, Washington D.C. 57. Murray S, Dillon BE, Haverkorn RM, and Lemack GE: When are video urodynamics really necessary in patients with spinal cord injury? Predictors of positive fluoroscopic findings during urodynamic testing. Poster presentation at SUFU annual meeting, March 2011, Scottsdale, AZ. 58. Dillon BE, Murray S, Haverkorn RM, Zimmern PE, and Lemack GE: Bladder function after mesh sling excision – Are satisfactory voiding symptoms achieved? Poster presentation at SUFU annual meeting, March 2011, Scottsdale, AZ. 59. Dillon BE, Haverkorn RM, Murray S, Frohman EM, Zimmern PE, and Lemack GE: LUTS progression in women with MS is not inevitable regardless of severity of neurological disease. Poster presentation at SUFU annual meeting, March 2011, Scottsdale, AZ. 60. Dillon BE, Haverkorn RM, Murray S, Frohman EM, Zimmern PE, and Lemack GE: Urodynamic predictors of lower urinary tract symptom progression in multiple sclerosis: do specific findings predict those destined to progress? Poster presentation at SUFU annual meeting, March 2011, Scottsdale, AZ 60. Kennelly M, Wychosky L, Lemack GE, Steers WD, Shenot P. Intradetrusor Injection of Onabotulinumtoxin A Improves Clinical and Urodynamic Outcomes in

Last Revised: April 9, 2015

Patients with Neurogenic Detrusor Overactivity Related to Spinal Cord Injury. Podium presentation North American Spine Society Meeting, 2011 61. Murray S, Dillon B, Haverkorn R, Lemack GE. Prevalence of upper tract abnormalities in a contemporary series of spinal cord injured patients. Poster presentation at AUA, May 2011. 62. Hall SA, Curto TM, Onyenyi A, Lemack GE, Tennstedt S, Link CL, McKinlay JB. Characteristics of persons with overactive bladder of presumed neurologic origin: Results from a community-based study. Poster presentation at AUA, May 2011. 63. Twenty-four month outcomes of the randomized equivalence trial of retropubic and transobturator midurethral slings. Albo M, Litman H, Lemack G, Richter H, Chai T, Kenton K, Kraus S, Sirls L, Zyczynski H, Norton P, Gormley A, Kusek J. Poster presentation at AUA May 2011. 64. Zimmern PE, Zhao H, Dickinson T, Xie XJ, Lemack GE. Final office evaluation findings in E-SISTER participants at one center: A glimpse into the long-term results of stress incontinence surgery. Abstract no. 178, 2012 European Association of Urology, Paris, France, February 24 – 27, 2012. 65. Lee D, Dillon BE, Lemack GE, Gomelsky A, Zimmern PE. Anterior transvaginal mesh – how “serious” are the complications and are they reversible? Abstract no. 180, 2012 European Association of Urology, Paris, France, February 24 – 27, 2012. 66. Philippe Zimmern, Hong Zhao, Tamara Dickinson, Xian-Jin Xie and Gary Lemack. Final office evaluation findings in E-SISTER participants at one center: A glimpse into the long-term results of stress incontinence surgery. Podium #3, Society for Urodynamics and Female Urology (SUFU), February 28 – March 3, 2012. 67. Benjamin Dillon, Casey Seideman, Michelle Van Kuiken, Dominic Lee, Elliot Frohman and Gary Lemack. Poster #M2, Society for Urodynamics and Female Urology (SUFU), February 28 – March 3, 2012. 68. Dominic Lee, Benjamin Dillon, Gary Lemack, Alex Gomelsky, and Philippe Zimmern. Anterior transvaginal mesh – how “serious” are the complications and are they reversible? Poster #NM13, Society of Urodynamics and Female Urology (SUFU), February 28 – March 3, 2012. 69. Gary Lemack, Heather Litman, Charles Nager, Linda Brubaker, Jerry Lowder, Peggy Norton, Larry Sirls, Keith Lloyd, and John Kusek. Preoperative clinical, demographic and urodynamic measures associated with failure to demonstrate urodynamic stress incontinence in women enrolled in two randomized clinical trials of surgery for stress urinary incontinence. Podium 10, Society of Urodynamics and Female Urology (SUFU), February 28 – March 3, 2012. 70. Casey Seideman, Benjamin Dillon, Dominic Lee, Claus Roehrborn, Philippe Zimmern and Gary Lemack. Transurethral resection of the prostate in neurogenic patients. Poster #NM32, Society of Urodynamics and Female Urology (SUFU), February 28 – March 3, 2012.

Last Revised: April 9, 2015

71. Benjamin Dillon, Casey Seideman, Dominic Lee, and Gary Lemack. Transitioning care in adults with myelomeningocele – lessons learned from a tertiary neurogenic bladder clinic. Poster #NM42, Society of Urodynamics and Female Urology (SUFU), February 28 – March 3, 2012. 72. Casey Seideman, Benjamin Dillon, Michelle Van Kuiken, Dominic Lee, Benjamin Greenberg, and Gary Lemack. The prevalence of pelvic organ prolapse is low among women with multiple sclerosis evaluated at a tertiary neurourology clinic. Podium #19, Society of Urodynamics and Female Urology (SUFU), February 28 – March 3, 2012. 73. Philippe Zimmern, Hong Zhao, Tamara Dickinson, Xian-Jin Xie, Gary Lemack: Final office evaluation findings in E-sister participants at one center: a glimpse into the long-term results of stress incontinence surgery. J Urology 187, No. 4 Supplement (Abstract no. 1186) 2012. 74. Michael Kennelly, Roger Dmochowski, Karen Ethans, Gilles Karsenty, Gary Lemack, Heinrich Schulte-Baukloh, Brenda Jenkins, Catherine Thompson, Daniel Li, Cornelia Haag-Molkenteller: Long-term efficacy and safety of onabotulinumtoxin A in patients with urinary incontinence due to neurogenic detrusor overactivity. J Urology 187, No. 4 Supplement (Abstract no. 1655) 2012. 75. Benjamin Dillon, Casey Seideman, Dominic Lee, Gary Lemack: Transitioning care in adults with myelomeningocele – Lessons learned from a tertiary neurogenic bladder clinic. J Urology 187, No. 4 Supplement (Abstract no. 1660) 2012. 76. Benjamin Dillon, Casey Seideman, Michelle Van Kuiken, Dominic Lee, Elliot Frohman, Gary Lemack: A surprisingly low prevalence of demonstrable stress urinary incontinence in women with multiple sclerosis followed at a tertiary neurourology clinic. J Urology 187, No. 4 Supplement (Abstract no. 1878) 2012. 77. Dominic Lee, Benjamin Dillon, Gary Lemack, Alexander Gomelsky, Philippe Zimmern: Anterior transvaginal mesh – how “serious” are the complications and are they reversible? J Urology 187, No. 4 Supplement (Abstract no. 2145) 2012. 78. Norton P, Nager C, Brubaker L, Lemack G, Lowder J, Chai T, Stoddard A: The cost of preoperative urodynamics: A secondary analysis of the VALUE trial. (Abstract 29) International Continence Society, Oct 15-19, 2012. 79. Sirls L, Richter H, Litman H, Kenton K, Lemack G, Lukacz E, Kraus SR, Goldman H, Weidener AC, Rickey LM, Norton P, Zyczynski HM: The effect of urodynamic testing on clinical diagnosis, treatment plan and outcomes in women undergoing stress urinary incontinence surgery. (Abstract 251) International Continence Society, Oct 15-19, 2012. 80. Kraus SR, Lemack G, Chai T, Sirls L, Lloyd K, Norton P, Mueller Ed, Menefee S, Shepherd J, Kusek J, Litman H: Comparison of urodynamic changes between autologous fascia pubovaginal sling and synthetic midurethral sling.(Abstract 252) International Continence Society, Oct 15-19, 2012.

Last Revised: April 9, 2015

81. Zimmern PE, Litman H, Lemack GE, Richter H, Sirls L, Kraus S. The effect of aging on voiding function in women with stress-preddominant urinary incontinence prior to surgical intervention. (Abstract 722) 28th Annual EAU Congress, March 15-19, 2013. 82. Lee D, Dillon B, Lemack G: Adult onset nocturnal enuresis: Identifying causes, cofactors and impact on quality of life. (Abstract no. 1042, The Journal of Urology, 189, S4, May 2013) 83. Hou J, Bacsu C, Zimmern P, Lemack G: Bladder neck closure in women: Lessons learned from a tertiary neurogenic bladder clinic. (Abstract no. 1422, The Journal of Urology, 189, S4, e582, May 2013) 84. Belsante M, Seideman C, Saraiya N, Lemack G, Zimmern P: How successful is suburethral synthetic tape removal? (Abstract no. 1572, The Journal of Urology, 189, S4, May 2013) 85. Lee D, Dillon B, Lemack G, Zimmern P: Long term outcomes following nonradiated vesico-vaginal fistula repair. (Abstract no. 1847, The Journal of Urology, 189, S4, May 2013) 86. Zimmern P, Litman H, Lemack G, Holly Richter, Stephen Kraus, Larry Sirls: Urodynamic parameters: Do they differ in women 65 years or older? (Abstract no. 2277, The Journal of Urology, 189, S4, May 2013) 87. Michael Belsante, Casey Seideman, Gary Lemack, Philippe Zimmern: How successful is suburethral synthetic tape removal? (Abstract Podium #8 South Central Section of the American Urological Association, 92nd Annual Meeting, September 18-21, 2013, Chicago, IL. 88. E. Ann Gormley, Linda Brubaker, Gary Lemack, Emily Lukacz, Stephen Kraus, Peggy Norton, Holly Richter, Leslie Rickey, Larry Sirls, Halina Zyczynski, Anne Stoddard, Hae-Young Kim: Predictors of surgical retreatment for stress urinary incontinence in women. (Abstract No. MP33-15, J Urol 191(4S), 2014. AUA National Meeting, May 16 – 21, 2014, Orlando, FL. 89. Philippe Zimmern, Omer Gulpinar, Alana Christie, Jack Hou, Feras Alhalabi, Gary E. Lemack: Reevaluation of cut-off values for bladder outlet obstruction based on pressure-flow studies from anatomically obstructed women. (Abstract No. MP75-18, J Urol 191(4S), 2014. AUA National Meeting, May 16 – 21, 2014, Orlando, FL. 90. Rebecca Lavelle, Burhan Coskun, Gary E. Lemack: Predicting which patients will only undergo a single onabotulinumtoxinA injection: Results from a tertiary referral center. (Abstract No. MP76-04, J Urol 191(4S), 2014. AUA National Meeting, May 16 – 21, 2014, Orlando, FL. 91. Rebecca Lavelle, Burhan Coskun, Louise A. Gliga, Benjamin Greenberg, Maude E. Carmel, Gary E. Lemack: Transverse myelitis patients require close urological surveillance: Results from a tertiary referral urodynamic center. (Abstract No. MP80-06, J Urol 191(4S), 2014. AUA National Meeting, May 16 – 21, 2014, Orlando, FL.

Last Revised: April 9, 2015

92. Rebecca Lavelle, Chasta D. Bacsu, Louise A. Gliga, Gary E. Lemack: Quality of life in neurogenic bladder patients after suprapubic tube placement. (Abstract No. MP8016, J Urol 191(4S), 2014. AUA National Meeting, May 16 – 21, 2014, Orlando, FL. 93. Rebecca Lavelle, MD, Louise A. Gliga, Alana L. Christie, Gary E. Lemack, MD: Utilizing more restrictive criteria for obtaining urodynamics in women with multiple sclerosis, does not result in more worrisome findings. (Poster #NM12). SUFU 2015 Winter Meeting, February 24 - 28, 2015, Scottsdale, AZ. 94. Himanshu Aggarwal, MD, MS, Philippe E. Zimmern, MD, Gary E. Lemack, MD.: Outcome of mid-urethral sling excision in patients with neurogenic bladder conditions. (Poster #NM15). SUFU 2015 Winter Meeting, February 24 - 28, 2015, Scottsdale, AZ. 95. Austin Younger, MD, Goran Rac BS, J. Quentin Clemens, MD, Kathleen Kobashi, MD, Aqsa Khan, MD, Victor Nitti, MD, Ilana Jacobs, MD, Gary E. Lemack, MD, Elizabeth T. Brown, MD, MPH, Roger Dmochowski, M.D, David Ginsberg, MD, Michelle Koski, MD, Ross Rames, MD, and Eric Rovner, MD: Changing practice patterns in vaginal mesh surgery for pelvic organ prolapse in tertiary care centers. (Poster #NM27). SUFU 2015 Winter Meeting, February 24 - 28, 2015, Scottsdale, AZ. 96. Austin Younger, MD, Goran Rac, BS, J. Quentin Clemens, MD, Kathleen Kobashi, MD, Aqsa Khan, MD, Victor Nitti, MD, Ilana Jacobs, MD, Gary E. Lemack, MD, Elizabeth T. Brown, MD, MPH, Roger Dmochowski, MD, David Ginsberg, MD, Michelle Koski, MD, Ross Rames, MD, and Eric Rovner, MD.: Changing practice patterns in vaginal mesh surgery for stress urinary incontinence in tertiary care centers. (Poster #NM28). SUFU 2015 Winter Meeting, February 24 - 28, 2015, Scottsdale, AZ.

ORIGINAL ARTICLES 1. Mills, I., Raasmaja, A., Moolten, N., Lemack, G., Silva, J., Larsen, P.: Effect of thyroid status on catecholamine stimulation of 5’-deiodinase in brown adipocytes. American Journal of Physiology, 256: 74-79, 1989. 2. Lemack, G.E., Poppas, D.P., Vaughan, E.D.: Urologic causes for gynecomastia: approach to diagnosis and management. Urology, 45: 313-319, 1995. 3. Uzzo, R.G., Lemack, G.E., Poppas, D.P.: Genitourinary reconstructive surgery using laser tissue welding. Techniques in Urology, 2: 55-61, 1995. 4. Lemack, G.E., Goldstein, M.: Presence of sperm in the pre-vasectomy reversal semen analysis: incidence and implications. Journal of Urology, 155: 167-169, 1996. 5. Poppas, D.P., Lemack, G.E., Mininberg, D.T.: Laparoscopic orchiopexy: clinical experience and description of technique. Journal of Urology, 155: 708-711, 1996. 6. Shin, D., Lemack, G.E., Goldstein, M.: Induction of spermatogenesis and pregnancy after adult orchiopexy. Journal of Urology, 158: 2242, 1997.

Last Revised: April 9, 2015

7. Lemack G.E., Uzzo, R.G., Schlegel, P.N., Goldstein, M.: Microsurgical repair of the adolescent varicocele. Journal of Urology, 160: 179, 1998. 8. Lemack, G.E., Szabo, Z., Urban, Z., Boyd, C., Csiszar, K., Vaughan, E.D., Felsen, D.: Altered bladder function in transgenic mice expressing rat elastin. Neurourology and Urodynamics 18: 55, 1999. 9. Lemack, G.E., Burkhard, F., Zimmern, P.E., McConnell, J.D., Lin, V.K.: Physiologic sequelae of partial infravesical obstruction in the mouse: role of inducible nitric oxide synthase. Journal of Urology 161: 1015, 1999. 10. Uzzo, R.G., Lemack, G.E., Morissey K.P., Goldstein M.: The effects of mesh bioprosthesis on spermatic cord structures: a preliminary report in a canine model. Journal of Urology 161: 1344, 1999. 11. Lemack, G.E., Zimmern, P.E, McConnell, J.D.: Outlet obstruction-Induced bladder dysfunction. AUA Update Series, Volume 18, Lesson 10, 1999. 12. Lemack, G.E., Foster, B., Zimmern, P.E.: Urethral dilation in women: a questionnaire-based analysis of practice patterns. Urology 54: 37-43, 1999. 13. Lemack, G.E., Zimmern, P.E.: Predictability of urodynamic findings based on the Urogenital Distress Inventory questionnaire. Urology 54: 461-466, 1999. 14. Lemack, G.E., Zimmern, P.E.: Female outlet obstruction and urodynamics. Issues in Incontinence Summer, 1999: 1, 7-9, 1999. 15. Lemack, G.E.: Reversing the tide: emerging options for treating overactive bladder symptoms in women. Texas Medicine 95: 78-81, 1999. 16. Lemack, G.E., Zimmern, P.E.: Treatment options for urinary incontinence in women. Resident and Staff Physician 46:35-46, 2000. 17. Lemack, G.E., Zimmern, P.E.: Identifying patients who require urodynamic testing prior to surgery for stress incontinence based on questionnaire information and surgical history. Urology 55: 506-511, 2000. 18. Lemack, G.E., Zimmern, P.E., Vazquez, D., McConnell, J.D., Lin, V.K.: Altered response to partial outlet obstruction in mice lacking inducible nitric oxide synthase. Journal of Urology 163: 1981-1987, 2000. 19. Lemack, G.E., Zimmern, P.E.: Pressure-flow analysis can aid in identifying women with outflow obstruction. Journal of Urology 163: 1823-1828, 2000. 20. Blander, D.S., Zimmern, P.E., Lemack, G.E., Sagalowsky, A.I.: Transvaginal repair of post-cystectomy peritoneovaginal fistulae. Urology 56: 320-321, 2000. 21. Lemack, G.E., Zimmern, P.E.: Sexual function after vaginal surgery for stress incontinence: results of a mailed questionnaire. Urology 56: 223-227, 2000.

Last Revised: April 9, 2015

22. Lemack, G.E., Dewey, R.B., Roehrborn, C.G., O’Suilleabhain, P.E., Zimmern, P.E.: Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson’s disease. Urology 56:250-254, 2000. 23. Lemack, G.E., Zimmern, P.E., Blander, D.S.: Levator myorraphy for vaginal vault prolapse. Urology 56 (6A): 50-54, 2000. 24. Burkhard, F.C., Lemack, G.E., Zimmern P.E., Lin V.K., McConnell, J.D.: Contractile protein expression in bladder smooth muscle is a marker of phenotypic modulation after outlet obstruction in rabbit model. Journal of Urology 165: 963-967, 2001. 25. Lemack, G.E.: Review of Neurology of Bladder, Bowel, and Sexual Dysfunction. Archives of Neurology 57: 1229-1230, 2000. 26. Lemack, G.E., Zimmern, P.E.: Reassessment of patients treated for interstitial cystitis not responding to standard therapies. Progres en Urologie 11: 239-244, 2001. 27. Margulis, V., Lemack, G.E., Molberg, K., Saboorian, M.H.: Urinary bladder mullerianosis in a woman with lower urinary tract symptoms and hematuria. Journal of Urology 165: 1996-1997, 2001. 28. Lemack, G.E.: Overactive bladder: optimizing quality of care. The American Journal of Managed Care 7 (2 supp): S46-61, 2001. 29. Burkhard F.C., Lemack G.E., Alcorn M.D., Zimmern P.E., Lin V.K., McConnell J.D.: Up-regulation of a gene homologous to the human tumor necrosis factor receptor associated factor 6 gene in the obstructed rabbit bladder determined by differential display polymerase chain reaction. Journal of Urology 165(3): 1289-93, 2001. 30. Lemack, G.E., Dewey, R.B., Roehrborn, C.G., O’Suilleabhain, P.E., Zimmern, P.E.: Questionnaire-based assessment of bladder dysfunction in patients with mild to moderate Parkinson’s disease (abstr.) Focus on Parkinson’s disease 13: 21-22, 2001. 31. Showalter P.R., Zimmern P.E., Roehrborn C.G., Lemack G.E.: Standing cystogram: an outcome measure after anti-incontinence procedures and cystocele repair in women? Urology 58: 33-37, 2001. 32. Baseman, A.G., Lemack, G.E.: Practical outcome measures following incontinence procedures. Current Urology Reports 2: 407-412, 2001. 33. Lemack, G.E., Blander D.S., Margulis V., Zimmern, P.E.: Vaginal vault fixation and prevention of enterocele recurrence by high midline levator myorraphy (HMLM): physical examination and questionnaire-based follow-up. European Urology 40:648651, 2001. 34. Lemack, G.E., Baseman, A.G., Zimmern, P.E.: Voiding dynamics in women: a comparison of pressure flow studies between asymptomatic and incontinent women. Urology 59:42-46, 2002. 35. Weber, A.M., Taylor, R.J., Wei, J.T., Lemack, G.E., Piedmonte, M.R., Walters. M.D.: Cost effectiveness of preoperative testing (basic office evaluation versus

Last Revised: April 9, 2015

urodynamics) for stress urinary incontinence in women. British Journal of Urology 89: 356-363, 2002. 36.

Lemack, G.E.: Urethral mass. Dallas Medical Journal 88: 185, 2002.

37. Wilson, T.S., Lemack, G.E., Dmochowski, R.R.: UroLume stents: Lessons learned. Journal of Urology 167: 2477-2480, 2002. 38. Baseman, A.G., Baseman, J.G., Zimmern P.E., Lemack, G.E.: Effects of a 6 french urethral catheter on urinary flow rates during repeated pressure flow studies in healthy female volunteers. Urology 59: 843-846, 2002. 39. Lemack, G.E.: Management and treatment of overactive bladder in the older female patient. Clinical Geriatrics 10: 32-45, 2002. 40. Abdel-Aziz K, Lemack, G.E.: Overactive bladder in the male patient. Current Urology Reports 3: 445-451, 2002. 41. Wilson, T.S., Lemack, G.E., Zimmern, P.E.: Treatment of intrinsic sphincteric deficiency. Journal of Urology 169: 1662-1669, 2003. 42. Lemack, G.E.: Sling materials: Are some ‘more equal than others’? AUA News, Volume 8: January 2003. 43. Gomelsky, A., Lemack, G.E., Weld, K., Dmochowski, R.R.: Urodynamic Patterns following ischemic spinal cord events. Journal of Urology 170: 122-125, 2003. 44. Lorenzo, A,J., Zimmern, P.E., Lemack, G.E., Nurenberg P.: Endorectal coil magnetic resonance imaging for diagnosis of urethral and periurethral pathologic findings in women. Urology 61: 1129-1134, 2003. 45. Lemack, G.E.: Clinical trial report: Urinary incontinence and depression in middle-aged women. Current Urology Reports 4: 373-374, 2003. 46. Defreitas G.A., Lemack G.E., Zimmern P.E., Dewey R.B., Roehrborn C.G., O’Suilleabhain P.E.: Distinguishing neurogenic from non-neurogenic detrusor overactivity: a urodynamic assessment of lower urinary tract symptoms in patients with and without Parkinson’s disease. Urology 62: 651-655, 2003. 47. Defreitas, G.A., Lemack, G.E., Zimmern, P.E.: Nonintubated uroflowmetry as a predictor of normal pressure flow study in women with stress urinary incontinence. Urology 62: 905-908, 2003. 48. Gupta, A., Defreitas, G.A., Lemack, G.E.: The reproducibility of urodynamic findings in healthy female volunteers: results of repeated studies in the same setting and at short-term follow-up. Neurourology and Urodynamics, 23: 311-316, 2004. 49. Defreitas, G.A., Zimmern, P.E. Lemack, G.E., Shariat, S.: Refining the diagnosis of anatomic female bladder outlet obstruction: a comparison of pressure-flow study parameters in clinically obstructed women to those of normal controls, Urology, 64: 675681, 2004.

Last Revised: April 9, 2015

50. Lemack, G.E.: Urodynamic assessment of patients with stress incontinence: how effective are urethral pressure profilometry and abdominal leak point pressure at case selection and predicting outcome? Current Opinion in Urology, 14: 307-311, 2004. 51. Lemack, G.E., Nitti, V.W., Winters, J.C. Urodynamically defined stress urinary incontinence and bladder outlet obstruction coexist in women: Eidtorial comments. J Urol, 171(21): 760-761, 2004. 52. Lemack GE. How many patients are required to achieve statistically significant results? Curr Urol Rep 6: 363, 2005. 53. Lemack GE. A prospective subjective and objective outcome analysis of tension-free vaginal tape. Curr Urol Rep 6: 363-4, 2005. 54. Lemack, G.E., Hawker K., Frohman E.: Incidence of upper tract abnormalities in patients with neurovesical dysfunction secondary to multiple sclerosis: an analysis of risk factors at initial presentation. Urology 65: 854-857, 2005. 55. Wilson, T.S., Abdel-Aziz, K., Vazquez, D., Wuermser, L.A., Lin, V.K., Lemack, G.E.: Changes in detrusor smooth muscle myosin heavy chain isoform expression following spinal cord injury in the mouse. Neurourology and Urodynamics, 24: 89-95, 2005. 56. Lemack, G.E.: Urodynamic assessment of bladder outlet obstruction in women. Nature Clinical Practice Urology 3: 38-44, 2006. 57. Gilleran, J., Lemack, G.E., Zimmern, P.E. Reduction of moderate-to-large cystocele during urodynamic evaluation using a vaginal gauze pack: 8-year experience. BJU International 97: 292-295, 2006. 58. Lemack, G.E., Frohman E., Zimmern P.E., Hawker K, Ramnarayan P: Urodynamic Distinctions between Idiopathic Detrusor Overactivity and Detrusor Overactivity Secondary to Multiple Sclerosis. Urology 67: 960-964, 2006. 59. Lemack, G.E., Siegel S., Comiter C., Damaser, M., Kobashi, K., Payne, C., Rodriguez, L.V., Wright, E.J.: Highlights from the Combined Society of Urodynamics and Female Urology and International Society of Pelvic Neuromodulation Annual Meeting. Journal of Urology, 175: 1852-1857, 2006. 60. Lemack, G.E.: Assessment of urethral sphincter function in women: What is best and does it matter? AUA News, January 2006. 61.

Lemack, G.E. Editorial comment. Urology, 67(4): 736, 2006.

62. Lemack, G. Central acute D2 stimulation worsens bladder function in patients with mild Parkinson’s disease: Commentary. J Urol 175(1): 206-207, 2006. 63. Lemack, G.E. Re: Martin JL, Williams KS, Sutton AJ, Abrams KR, Assassa RP. 2006. Systematic review and meta-analysis of methods of diagnostic assessment for urinary incontinence. Neurourol Urodynam 25: 674-683. Neurourology and Urodynamics, 25(7): 684, 2006.

Last Revised: April 9, 2015

64. Lemack, G.E., Xu Y, Brubaker L, Nager C, Chai T, Moalli P, Kraus S, Kerr L, Sirls L, Stoddard for the Urinary Incontinence Treatment Network.: Clinical and Demographic Factors Associated with Valsalva Leak Point Pressure among Women Undergoing Burch Bladder Neck Suspension or Autologous Rectus Fascial Sling Procedures. Neurourology and Urodynamics 26: 392-396, 2007. 65. Lemack, G.E., Amundsen, C., Badlani, G., Griebling, T., Peters, K., Rodriguez, L., Singla, A., Smith, C., Sullivan, M., Te A.: Highlights from the Combined Society of Urodynamics and Female Urology and International Society for Pelvic Neuromodulation Annual Meeting. Journal of Urology 177: 691-695, 2007. 66. Lemack, G.E., Frohman E., Ramnarayan, P: Women with voiding dysfunction secondary to bladder outlet dyssynergia in the setting of multiple sclerosis do not demonstrate significantly elevated intravesical pressures. Urology 69: 893-897, 2007. 67. Lemack, G.E. Defining the role for OAB treatments in men with lower urinary tract symptoms. Nature Clinical Practice Urology 4: 174-175, 2007. 68. Lemack, G.E. Incontinence: Helping women stay in control. Cortland Forum 5354, January 2007. 69. Lemack, G.E. Use of urodynamics prior to surgery for urinary incontinence: how helpful is preoperative testing? Indian Journal of Urology 23: 142-147, 2007. 70. Albo, M, Richter H.E., Brubaker L., Norton P., Kraus S.R., Zimmern P.E., Chai T.C., Zyczynski H., Diokno A.C., Tennstedt S., Nager C., Lloyd L.K., Fitzgerald M., Lemack, G.E., Johnson H.W., Leng W., Mallett V., Stoddard A.M., Menefee S., Varner R.E., Kenton K., Moalli P., Sirls L., Dandreo K.J., Kusek J.W., Nyberg L.M., Steers W., for the Urinary Incontinence Treatment Network. Burch colposuspension versus fascial sling to reduce urinary stress incontinence. New England Journal of Medicine 356: 2143-2155, 2007. 71. Albo M. Wruck L. Baker J. Brubaker L. Chai T. Dandreo KJ. Diokno A. Goode P. Kraus S. Kusek JW, Lemack G. Lowder J. Steers W. Urinary Incontinence Treatment Network. The relationships among measures of incontinence severity in women undergoing surgery for stress urinary incontinence. Journal of Urology. 177:1810-4, 2007 72. Lee, U., Baskin L., Schaefer W., Lemack G.E., Wein A.J., Daneshgari F.: Highlights of the Urethral Dysfunction Sessions at the Society for Urodynamics and Female Urology. Current Bladder Dysfunction Reports 2: 71-76, 2007. 73. Lemack GE. Reply to the editor by B.L.H. Bemelmans. Re: Lemack et al. 2007. Clinical and demographic factors associated with valsalva leak point pressure among women undergoing burch bladder neck suspension or autologous rectus fascial sling procedures. Neurourol Urodynam 26:392-6. Neurology and Urodynamics, 26(6): 896, 2007. 74. Lemack, G.E.: Lower urinary tract dysfunction in the diabetic elderly. Aging Health 3(5): 647-651, 2007.

Last Revised: April 9, 2015

75. Lemack, G.E.: Assessing the Natural History of Lower Urinary Tract Symptoms without Incontinence in Women: What have we learned and where are we headed? European Urology 52: 1576-1578, 2007. 76.

Lemack, G.E. Editorial comment. J Urol, 178(3): 963-964, 2007.

77.

Lemack, G.E. Editorial comment. J Urol, 178(3): 969, 2007.

78. Lemack, G.E.: Intradetrusor botulinum toxin injections for neurogenic overactive bladder: Are we there yet? European Urology 53: 240-241, 2008. 79. Fletcher SG, Lemack GE. Re: Woodruff et al.: Histologic comparison of pubovaginal sling graft materials: a comparative study (Urology 2008; 72-85-89). Urology 72: 721-2; author reply 722, 2008. 80. Nager, C.W., Fitzgerald M, Kraus S.R., Chai, T.C., Zyczynski H., Sirls L., Lemack, G.E., Lloyd L.K., Stoddard A.M., Baker, J., Steers, W.D.: for the UITN. Urodynamic Measures do not Predict Stress Incontinence Outcomes after Surgery for Stress Urinary Incontinence in Selected Women. Journal of Urology 179: 1470-1474, 2008. 81. Burgio, KL, Kraus, SR, Menefee, S, Borello-France, D, Corton, M, Johnson, HW, Mallett, V, Norton, P, FitzGerald, MP, Dandreo, KJ, Richter, HE, Rozanski, T, Albo, M, Zyczynski,HM, Lemack, G.E., Chai, TC, Khandwala S, Baker J, Brubaker L, Stoddard AM, Goode PS, Nielsen-Omeis B, Nager, CW, Kenton, K, Tennstedt, SL, Kusek, JW, Chang, D, Nyberg, LM, Steers, W, for the Urinary Incontinence Treatment Network. Behavioral therapy to enable women with urge incontinence to discontinue drug treatment. Annals of Internal Medicine 149(3):161-169, 2008. 82. Albo, ME, Richter, HE, Brubaker, L, Norton, PA, Kraus, SR, Zimmern, P, Lemack, GE, Johnson, HW, Kusek, JW, Nyberg Jr., LM, Steers, WD. UIJ- Results of the SISTEr randomized surgical trial comparing the autologous rectus fascia sling to the burch colposuspension. UroToday International Journal 1, (1 Suppl), 2008. 83. Kraus, SR, Lemack, GE, Chai, T, Richter, HE, Albo, ME, Brubaker, L, Sirls, L, Litman, H, Norton, PA, Leng, W. UIJ – Urodynamic changes 24 months after burch colposuspension and autologous fascia pubovaginal sling. UroToday International Journal, 1 (1 Suppl), 2008. 84. Lemack, GE, Kraus, SR, Litman, H, FitzGerald, MP, Chai, T, Nager, CW, Sirls, L, Zyczynski, H, Baker, J, Lloyd, LK, Steers, WD. UIJ – Preoperative urodynamic testing does not predict postoperative voiding dysfunction among women undergoing surgery for SUI: Results from a prospective randomized trial comparing Burch versus Pubovaginal Sling. UroToday International Journal, 1 (1 Suppl), 2008. 85. Kraus, SR, Lemack, GE, Brubaker, L, Chai, T, Albo, ME, Litman, H, Leng, W, Sirls, L, Lloyd, LK, Norton, PA. UIJ – Urodynamic changes associated with successful stress urinary incontinence surgery: A little tension is a good thing? UroToday International Journal, 1 (1 Suppl), 2008.

Last Revised: April 9, 2015

86. Albo, ME, Steers, W, Diokno, A, Khandwala, S, Brubaker, L, Nager, C, Zimmern, P, Lemack, G, Kraus, S. Kusek, JW, Nyberg, LM, Weber, AM. The trial of mid-urethral slings (TOMUS): Design and methodology. Journal of Applied Research, 8(1): 1-13, 2008. 87. Lemack GE. Editorial comment on: Genetic influence on stress urinary incontinence and pelvic organ prolapse. European Urology 54: 923, 2008. 88. Lemack, G.E., Kraus, S, Litman H, Fitzgerald, MP, Chai, T, Nager, C, Sirls, L, Zyczynski, H, Baker, J, Lloyd, K and Steers, WD for the Urinary Incontinence Treatment Network. Normal preoperative urodynamic testing does not predict postoperative voiding dysfunction after Burch colposuspension versus pubovaginal sling. Journal of Urology 180: 2076-2080, 2008. 89. Fitzgerald, M.P., Lemack, G.E., Wheeler T, Litman HJ for the Urinary Incontinence Treatment Network. Nocturia, nocturnal incontinence prevalence and response to anticholinergic and behavioral therapy. Int Urogyn J 19: 1545-50, 2008. 90. Fletcher SG, Lemack G.E., “Clarifying the role of urodynamics in the preoperative evaluation of stress urinary incontinence.” The Scientific World Journal 8: 1259-1268, 2008. 91. Fletcher SG, Lemack, G.E.: “Benign masses of the female periurethral tissues and anterior vaginal wall,” Current Urology Reports 9: 389-396, 2008. 92. Wei J, Nygaard I, Richter H, Daneshgari F, Amundsen C, Loomis MJ, Brubaker L, Nager CW, Lemack G, Meikle S. Outcomes following vaginal prolapse repair and mid urethral sling (OPUS) trial – Design and methods. Clinical Trials 6(2): 162-171, 2009. 93. Fletcher, SG, Castro-Borrero W, Remington G, Treadaway K, Lemack G.E., Frohman EM Sexual dysfunction in patients with multiple sclerosis: a multidisciplinary approach to evaluation and management. Nat Clin Pract Urol. 2009 Feb;6(2):96-107. 94. Nager CW, Brubaker L, Daneshgari F, Litman HJ, Dandreo KJ, Sirls L, Lemack GE, Richter HE, Leng W, Norton P, Kraus SR, Chai TC, Chang D, Amundsen CL, Stoddard AM, Tennstedt SL, and the Urinary Incontinence Treatment Network. Design of the value of urodynamic evaluation (ValUE) trial: A non-inferiority randomized trial of preoperative urodynamic investigations. Contemporary Clinical Trials 30: 531-539, 2009. 95. Haverkorn R, Lemack GE. Editorial comment on: Medium-term anatomic and function results of laparoscopic sacrocolpopexy beyond the learning curve. European Urology 55: 1467-1468, 2009. 96. Kennelly MJ, Lemack GE, Foote JE, Trop CS. Efficacy and safety of oxybutynin transdermal system in spinal cord injury patients with neurogenic detrusor overactivity and incontinence: an open label, dose titration study. Urology 74: 741-745, 2009. 97. Fletcher SG, Lemack GE. Evaluation and management of neurogenic vesicourethral dysfunction in multiple sclerosis. Current Bladder Reports 4(2): 71-78, 2009.

Last Revised: April 9, 2015

98. Kenton K, Richter H, Litman H, Lukacz E, Weng W, Lemack G, Chai T, Arisco A, Tennstedt S, Steers W, Urinary Incontinence Treatment Network. Risk factors associated with urge incontinence after continence surgery. Journal of Urology 182: 2805-2809, 2009. 99. Richter HE, Kenton K, Huang L, Nygaard I, Kraus S, Whitcomb E, Chai TC, Lemack GE, Sirls L, Dandreo K, Stoddard A. The impact of obesity on urinary incontinence symptoms, severity, urodynamic characteristics, and quality of life. Journal of Urology 183: 622-628, 2010. 100. Brubaker L, Rickey L, Xu Y, Ghetti, Lemack GE, Norton P, Pradeep, Markland, Kahn. Symptoms of combined prolapsed and urinary symptoms in large surgical cohorts. Obstetrics and Gynecology 115: 310-316, 2010. 101. Richter HE, Albo ME, Zyczynski HM, Kenton K, Norton PA, Sirls LT, Kraus SR, Chai TC, Lemack GE, Dandreo KJ, et al, Retropubic versus Transobturator Midurethral Slings for Stress Incontinence. New England Journal of Medicine 362: 22: 2066, 2010. 102. Murray S, Lemack GE. Defining the role of urodynamics in predicting voiding dysfunction after anti-incontinence surgery: a work in progress. Curr Opin Urol 20: 28590, 2010. 103. Zimmern P, Kobashi K, Lemack G. Outcome measures for stress urinary incontinence (OMIT): Results of two Society of Female Urology and Urodynamics (SUFU) Surveys. Neurourology and Urodynamics 29: 715-718, 2010. 104. Murray S, Lemack GE: Overactive bladder and mixed incontinence. Curr Urol Rep 2010 Nov, 11(6): 385-392. 105. Fletcher SG, Haverkorn RM, Yan J, Lee JJ, Zimmern PE, Lemack GE: Demographic and urodynamic factors associated with persistent OAB after anterior compartment prolapse repair. Neurourol Urodyn 29: 1414-1418, 2010. 106. Haverkorn RM, Lemack GE. Editorial Comment. Regarding Transobturator tension-free vaginal tape for management of occult SUI in women undergoing pelvic organ prolapse repair. Urology 76: 1361-2; author reply 1363, 2010. 107. Frohman EM, Courtney A, Castro W, Burton E, Graves D, Remington G, Treadaway K, Bates A, Shah A, Lemack GE, Hart J, Greenberg B: Symptomatic therapy in multiple sclerosis. Therapeutic Advances in Neurological Disorders 4(2): 83 – 98, 2011. 108. Murray S, Haverkorn RM, Lotan Y, Lemack GE: Mesh kits for anterior vaginal prolapse are not cost effective. International Urogynecology Journal 22: 447-452, 2011. 109. Murray S, Haverkorn RM, Koch YK, Lemack GE, Zimmern PE: Urethral distortion after placement of synthetic mid urethral sling. J Urol. 185(4): 1321-1326, 2011. 110. Richter HE, Litman HJ, Lukacz ES, Sirls LT, Rickey L, Norton P, Lemack GE, Kraus S, Moalli P, Fitzgerald MP, Dandreo KJ, Huang L, Kusek JW; for the Urinary

Last Revised: April 9, 2015

Incontinence Treatment Network. Demographic and Clinical Predictors of Treatment Failure One Year After Midurethral Sling Surgery. Obstet Gynecol 117: 913-921, 2011. 111. Sanses TV, Brubaker L, Xu Y, Kraus SR, Lowder JL, Lemack GE, Norton P, Litman JH, Tennstedt SL, Chai TC: Preoperative hesitating urinary stream is associated with postoperative voiding dysfunction and surgical failure following Burch colposuspension or pubovaginal rectus fascial sling surgery. Int Urogynecol J Pelvic Floor Dysfunct 22: 713-719, 2011. 112. Nager CW, Sirls L, Litman HJ, Richter H, Nygaard I, Chai T, Kraus S, Zcczynski H, Kenton K, Huang L, Kusek J, Lemack GE for the UITN: Baseline urodynamic predictors of treatment failure 1 year after mid urethral sling surgery. J Urology 186: 597-603, 2011. 113. Dillon B, Lemack GE: A comprehensive review of common neurogenic bladder disorders. Annals of Urology, San Lucas Medical, LLC 11/28/2011. 114. Murray S, Lemack GE: Multiple Sclerosis and voiding dysfunction in women. Current Bladder Dysfunction Reports 6:142-149, 2011. 115. Brubaker L, Norton PA, Albo ME, Chai TC, Dandrreo KJ, Lloyd KL, Lowder JL, Sirls LT, Lemack GE, Arisco AM, XU Y, Kusek JW; Urinary Incontinence Treatment Network. Adverse events over two years after retropubic or transobturator midurethral sling surgery: findings from the Trial of Midurethral Slings (TOMUS) study. Am J Obstet Gynecol 205(5):498.e1-6, 2011. 116. Kraus SR, Lemack GE, Richter HE, Brubaker L, Chai TC, Albo ME, Sirls LT. Leng WW, Kusek JW, Norton P, Litman HJ; Urinary Incontinence Treatment Network. Changes in urodynamic measures two years after burch colposuspension or autologous sling surgery. Urology 78: 1263-1268, 2011. 117. Kraus SR, Lemack GE, Sirls LT, Chai TC, Brubaker L, Albo M, Leng WW, Lloyd LK, Norton P, Litman HJ; Urinary Incontinence Treatment Network. Urodynamic changes associated with successful stress urinary incontinence surgery: is a little tension a good thing? Urology 78: 1257-1262, 2011. 118. Nager CW, Brubaker L, Litman HJ, Zyczynski HM, Varner RE, Amundsen C, Sirls LT, Norton PA, Arisco A, Chai TC, Zimmern PE, Barber MD, Dandreo KJ, Menefee SA, Kenton K, Lowder J, Richter HE, Khandwala S, Nygaard I, Kraus SR, Johnson HW, Lemack GE, Mihova M, Albo ME, Mueller E, Sutkin G, Wilson TS, Hsu Y, Rozanski T, Rickey L, Rahn D, Tennstedt S, Kusek JW, Gormley EA, for the UITN. A randomized trial of urodynamic testing before stress incontinence surgery. NEJM 366: 1987-1997, 2012. 119. Hall SA, Curto TM, Onyenwenyi A, Lemack GE, Tennstedt SL, Link CL, McKinlay JB. Characteristics of persons with overactive bladder of presumed neurologic origin: Results from the Boston Area Community Health (BACH) Survey. Neurourol Urodynam 31: 1149-1155, 2012. 120. Cornu JN, Abrams P, Chapple CR, Dmochowski RR, Lemack GE, Michel MC, Tubaro A, Madersbacher S. A contemporary assessment of nocturia: Definition,

Last Revised: April 9, 2015

epidemiology, pathophysiology, and management-a systematic review and metaanalysis. Eur Urol 62(5): 877-890, 2012. 121. Dillon BE, Lee D, Lemack GE. Urodynamics: role in incontinence and prolapse: a urology perspective. Urol Clin North Am 39: 265-272, 2012. 122. Albo ME, Litman HJ, Richter HE, Lemack GE, Sirls LT, Chai TC, Norton P, Kraus SR, Zyczynski H, Kenton K, Gormley EA, Kusek JW; Urinary Incontinence Treatment Network. Treatment success of retropubic and transobturator mid urethral slings at 24 months. J Urol 188(6): 2281-2287, 2012. 123. Winters JC, Dmochowski RR, Goldman HB, Herndon CD, Kobashi KC, Kraus SR, Lemack GE, Nitti VW, Rovner ES, Wein AJ. Urodynamic studies in adults: AUA/SUFU Guideline. J Urol 188: 2464-2472, 2012. 124. Sirls LT, Richter HE, Litman HJ, Kenton K, Lemack GE, Lukacz ES, Kraus SR, Goldman HB, Weidner A, Rickey L, Norton P, Zyczynski HM, Kusek JW; Urinary Incontinence Treatment Network. The effect of urodynamic testing on clinical diagnosis, treatment plan and outcomes in women undergoing stress urinary incontinence surgery. J Urol 189: 204-209, 2013. 125. Fletcher SG, Dillon BE, Gilchrist AS, Haverkorn FM, Yan J, Frohman EM, Lemack GE. Renal deterioration in multiple sclerosis patients with neurovesical dysfunction. Mult Scler. 19:1169-1174, 2013. 126. Lee D, Dillon B, Lemack G, Gomelsky A, Zimmern P. Transvaginal mesh kits – How “serious” re the complications and are they reversible? Urology 81(1): 43-48, 2013. 127. Lemack GE, Litman HJ, Nager C, Brubaker L, Lowder J, Norton P, Sirls L, Lloyd K, Kusek JW for the UITN. Preoperative Clinical, Demographic and Urodynamic Measures Associated with Failure to Demonstrate Urodynamic Stress Incontinence in Women Enrolled in Two Randomized Clinical Trials of Surgery for Stress Urinary Incontinence. International Urogynecology Journal 24: 269-274, 2013. 128. Dillon BE, Seideman CA, Lee D, Greenberg B, Frohman EM, Lemack GE. A surprisingly low prevalence of demonstrable stress urinary incontinence and pelvic organ prolapse in women with multiple sclerosis followed at a tertiary neurogenic bladder clinic. Journal of Urology, 189(3): 976-979. 2013. 129. Norton PA, Nager CW, Chai TC, Mueller E, Stoddard A, Lowder J, Varner E, Lemack G. Risk factors for incomplete bladder emptying after midurethral sling. Urology 82(5): 1038-1041, 2013. 130. Hou JC, Lemack GE. The role of fascial slings in the treatment of stress urinary incontinence in women: A 2013 update. Curr Urol Rep 14(3): 247-52, 2013. 131. Lee D, Dillon BE, Lemack GE, Zimmern PE. Long-term functional outcomes following nonradiated vesicovaginal repair. J Urol. 2014 Jan; 191(1): 120-4.

Last Revised: April 9, 2015

132. Lemack GE. Percutaneous tibial nerve stimulation for refractory lower urinary tract symptoms in patients with neurogenic bladder conditions. J Urol. 2014 Mar; 191(3): 582-3. 133. Zimmern P, Litman JH, Nager CW, Lemack GE, Richter HE, Sirls L, Kraus SR, Sutkin G, Mueller ER. Effect of aging on storage and voiding function in women with stress-predominant urinary incontinence. J Urol. 2014 Aug; 192(2):464-8. 134. Dillon BE and Lemack GE. Urodynamics in the evaluation of the patient with multiple sclerosis: When are they helpful and how do we use them? Urologic Clinics of North America. Urol. Clin. North Am. 2014 Aug; 41(3):439-44. 135. Hou JC, Alhalabi F, Lemack GE, Zimmern PE. Outcome of trans-vaginal mesh and tape removed for pain only. J Urol. 2014 Sep; 192(3):856-60. 136. Norton PA, Nager CW, Brubaker L, Lemack GE, Sirls LT, Holley R, Chai TC, Kraus SR, Zyczynski H, Smith B, Sotddard A. The cost of preoperative urodynamics: A secondary analysis of the ValUE trial. Neurourol. Urodyn. 2014 Oct 18 [Epub ahead of print]. 137. Coskun B, Lavelle RS, Alhalabi F, Lemack GE, Zimmern PE. Mini-slings can cause complications. Int. Urogynecol J. 2015; 26(4): 557-62. 138. Norton P, Brubaker L, Nager CW, Lemack GE, Zyczynski HM, Sirls L, Rickey L, Stoddard A, Varner RE. Pelvic organ prolapse in a cohort of women treated for stress urinary incontinence. Am. J. Obstet. Gynecol. 2014 Nov; 211(5):550.e1-5. 139. Simhan,J., Morey, A.F., Singla, N., Tausch, T.J., Scott, J. F., Lemack, G.E., Roehrborn, C.G.: 3.5 cm Artificial urinary sphincter cuff erosion occurs predominantly in irradiated patients. J. Urol. 2015 Feb; 193(2):593-597. 140. Aggarwal, H., Lavelle, R., Lemack, GE.: Female Urinary Incontinence: The Value and Challenges of Randomized Controlled Trials. AUA Update Series, Volume 34, Lesson 12, 2015. 141. Lemack GE. Urinary Considerations in Spinal Dysraphism. PracticeUpdate website. Available at http://www.practiceupdate.com/c/26336/1/3. Accessed July 7, 2015. 142. Lemack GE. Primary Bladder Neck Obstruction in Men and Women: an Update on Diagnosis and Management. Current Bladder Dysfunction Reports. 2015. (DOI)10.1007/s11884-015-0315-6. 143. Lavelle RS, Coskun B, Bacsu CD, Gliga LA, Christie AL, Lemack GE. Quality of life after suprapubic catheter placement in patients with neurogenic bladder conditions. Neurourol Urodyn 2014 Jul 21. [Epub ahead of print] PMID: 26197729. 144. Coskun B, Lavelle RS, Alhalabi F, Lemack G, Zimmern PE. Urodynamics for incontinence after midurethral sling removal. Neurourol Urodyn 2015 Jul 24. [Epub ahead of print] PMID: 26207847.

Last Revised: April 9, 2015

145. Lemack G, Gliga L. Urodynamics Findings in Transverse Myelitis Patients With Lower Urinary Tract Symptoms: Results From a Tertiary Referral Urodynamic Center Neurourol Urodyn 2015 Nov 2. [Epub ahead of print] https://mc.manuscriptcentral.com/neurourol PMID:

CHAPTERS 1. Lemack, G.E., Uzzo, R.G., Poppas, D.P.: “The effect of stress on male reproductive function.” In Hubbard, J.R., Workman, E.A (eds.) Handbook of Stress Medicine: An Organ System Approach. CRC Press, NY, NY, 1997. 2. Lemack, G.E., Raz, S., Young, G.P.H.: “Fisiopatologia e Tratamento dos Prolapsos Vagainais.” In Rubinstein, I. (ed.) Urologia Feminina. Blk Foundation, Sao Paulo, Brazil, 1998. 3. Lemack, G.E., McConnell, J.D.: “Bladder responses to obstruction.” In Kirby, R.S., McConnell, J.D., Fitzpatrick, J.M., Roehrborn, C.G., Boyle, P. (eds.) Textbook of benign prostatic hyperplasia, 2nd Ed., Isis Medical Media Ltd., Oxford, 2005. 4. Lemack, G.E., Zimmern, P.E.: “Voiding cystourethrography and magnetic resonance imaging of the lower urinary tract.” pp. 407-422, In Corcos, J., Schick, E. (eds.) The Urinary Sphincter, Marcel Dekker, Inc., NY, NY, 2001. 5. Lemack, G.E., Zimmern, P.E.: “Endofascial reconstruction of vaginal prolapse: the levator myorraphy.” pp. 179-192, In Stanton, S.L., Zimmern, P.E. (eds.) Female Reconstructive Surgery, Springer-Verlag, London Ltd., London, 2002. 6. Wilson, T., Lemack, G.E.: “Transvaginal procedures for stress urinary incontinence.” Pp. 137-160 In Carlin, B.I., Leong F.C. (eds.) Female Pelvic Health and Reconstructive Surgery, Marcel Dekker Inc., NY NY, 2002. 7. Lemack, G.E., Zimmern, P.E.: “Voiding difficulties.” Pp 803-812, in Shaw, R., Soutter, P., Stanton, S.L. (Ed) Gynaecology, 3e, Harcourt Publishers Ltd., London, 2003. 8. Lemack, G.E., Zimmern P.E.: “Transvaginal levator myorraphy for vaginal vault prolapse.” In Vasavada S.P., Appell R.A., Sand P., Raz, S. (eds.) Female Urology, Urogynecology and Voiding Dysfunction, Marcel Dekker, Inc., NY, NY (In press) 9. Lemack, G.E.: “Clinical evaluation” Pp. 361-365, In Corcos J, and Schick E (Eds) Neurogenic bladders in Adults and Children, Marcel Dekker, Inc., NY NY, 2004. 10. Baseman, A.G., Lemack, G.E.: “Evaluation: Outcome Measures for Assessing Efficacy of Incontinence” Pp. 75-87, In Zimmern PE, Norton P, Haab F, and Chapple C (Eds) Vaginal surgery for incontinence and prolapse, Springer-Verlag, London UK 2006. 11. Lemack, G.E.: “Neurogenic bladder: evaluation and management” pp. 343-353, In Chapple C, Zimmern PE, Brubaker L, Smith ARB, Norton C, Bo K (Eds)

Last Revised: April 9, 2015

Multidisciplinary management of female pelvic floor dysfunction, Elsevier, London UK, 2006. 12. Lemack,G.E.: “Voiding Dysfunction and Neurological Disorders” In Raz S, Rodriguez, L. (Eds) Female Urology, Elsevier, Philadelphia PA 2008. 13. Dugi, D., Lemack, G.E.: “Tricyclic Depressants,” Pp. 139-144 In Kreder K., and Dmochowski R (eds) The Overactive Bladder, Informa Healthcare 2007. 14. Cundiff, G., Lemack, G.E.: “Endoscopy: Urological and Gynaecological” Pp. 377-389 In Cardozo L, Staskin D (Eds) Textbook of Female Urology and Urogynecology, Martin Dunitz UK 2006. 15. Lemack, G.E.: “Urodynamic assessment of overactive neurogenic bladder” In Goldman H.B., Vasavada S.P. (Eds) Female Urology and Voiding Dysfunction, Humana Press, Totwa, NJ (in press). 16. Gilchrist, A.S., Lemack, G.E., Zimmern P.E.: “Surgical management of the incompetent bladder outlet in the patient with a neurogenic bladder.” In Graham S.D., Keane T.E. (Eds) Glenn’s Urologic Surgery, Lippincott, Williams and Wilkins, Philadelphia PA, 2011. 17. Dillon B.E., Lee D., Lemack G.E., “Lessons learned from a decade of multicenter cooperative clinical trials in stress urinary incontinence. Current Bladder Dysfunction Reports. In press. . 18. Lee D, Dillon B, Lemack G.E., LUTS in the patients with Parkinson’s Disease: evaluation and management. AUA Update Series 2012. 19. Lemack, G.E. “Stress incontinence and neurological dysfunction/ urodynamic loss of compliance.” In Goldman H and Vasavada S (Eds) Expert Opinions in Female Pelvic Medicine and Reconstructive Surgery. 2013. 20. Bacsu C, and Lemack, G.E.: “Clinical evaluation”, In Corcos J, Ginsberg D, and Schick E (Eds) Neurogenic bladders in Adults and Children, Marcel Dekker, Inc., NY NY, 2014. IN press. 21. Lemack, G.E., Tash J.T.: “Urinary Incontinence and Pelvic Prolapse: Epidemiology and Pathophysiology.” In Wein A, Kavoussi L, Partin A, Peters C (Eds) Campbell-Walsh Urology, Elsevier Inc., NY NY 2015 in press. 22. Lemack, G.E., Aggarwal, H., Harris, C.J.: “Complications of Bladder Augmentation and Surgery for Neurogenic Bladder.” Taneja’s Complications of Urologic Surgery: Prevention and Management, 5th Edition, Elsevier Inc., NY, NY 2016.

INVITED LECTURES 1. “Surgical management of pheochromocytoma,” Nassau County Medical Society, Division of Endocrinology Spring Meeting, April, 1996, East Meadow, NY.

Last Revised: April 9, 2015

2. “Urodynamic diagnosis of overactive bladder,” Overactive Bladder Symposium, Philippe E. Zimmern Director, October 1998, Dallas, TX. 3. “Surgical management of the overactive bladder,” Overactive Bladder Symposium, Philippe E. Zimmern Director, October, 1998, Dallas, TX. 4. “Outcome measures in female incontinence,” Fifth Annual Paul C. Peters Urology Symposium, John D. McConnell Director, October, 1998, Dallas, TX. 5. “Urethral dilation in women: practice patterns at the turn of the century,” Sixth Annual Paul C. Peters Urology Symposium, John D. McConnell Director, October, 1999, Dallas, TX. 6. “Sexual dysfunction after incontinence surgery,” 21st annual Society for Urodynamics and Female Urology Meeting, April 30, 2000, Atlanta, GA. 7. “Role of urodynamics prior to surgery for incontinence,” Seventh Annual Paul C. Peters Urology Symposium, John D. McConnell Director, October, 2000, Dallas, TX. 8. “Treatment of obstruction following surgery for incontinence,” Seventh Annual Paul C. Peters Urology Symposium, John D. McConnell Director, October, 2000, Dallas, TX. 9. “Urinary incontinence: etiology, and treatment options,” Physical therapy grand rounds, November, 2000, University of Texas Southwestern Medical Center, Dallas, TX. 10. 10 “Management of overactive bladder symptoms in men,” Interactive Forum on Lower Urinary Tract Health: Key issues, controversies, and treatment options. November 3-5, 2000, Miami, FL. 11. “Bladder and sexual dysfunction in the MS patient’” Multiple Sclerosis and the non-neurologist. Elliot Frohman Course Director, January, 2001, University of Texas Southwestern Medical Center, Dallas, TX. 12. “Urinary incontinence: Update 2001,“ Grand Rounds, Good Shepard Medical Center, Longview, TX, January 2001. 13. “Outcome assessments of treatment for incontinence,” Updates on Female Pelvic Medicine and Reconstructive Surgery, Firouz Daneshgari Course Director, March 2001, Breckenridge, CO. 14. “Female sexual dysfunction,” Updates on Female Pelvic Medicine and Reconstructive Surgery, Firouz Daneshgari Course Director, March 2001, Breckenridge, CO. 15. “Normal female pelvic anatomy,” Sling-a-thon: Dallas summit on vaginal sling procedures, April 2001

Last Revised: April 9, 2015

16. “Pubovaginal sling using cadaveric fascia,” Sling-a-thon: Dallas summit on vaginal sling procedures, April 2001 17. “Incontinence – what you can do to help yourself,” Deaf Action Center lecture series, Dallas, TX, May 2001. 18. “Topics in women's health 2001: Urinary incontinence, overactive bladder and female sexual dysfunction,” Obstetrics and Gynecology Grand rounds, Medical City of Dallas, August 2001. 19. “Options for pubovaginal sling procedures: promising technology or unchartered waters?” Eighth Annual Paul C. Peters Urology Symposium, Philippe E. Zimmern Director, University of Texas Southwestern Medical Center, Dallas, TX, January 2002. 20. “Urinary incontinence and overactive bladder: What’s new in 2002?” Department of Family Practice Grand Rounds, Charlton Methodist Hospital, Dallas, TX, February 2002. 21. “Update on management of urinary incontinence and neurogenic bladder.” Department of Nursing Grand Rounds, Urology Update, Parkland Memorial Hospital, Dallas, TX, February 2002. 22. “Stress Urinary Incontinence: New approaches to defining treatment success.” National Urology Resident Preceptorship Program in Female Pelvic Medicine and Reconstructive Surgery, Cleveland Clinic Foundation, April 2002. 23. “Update on Neurourology.” National Urology Resident Preceptorship Program in Female Pelvic Medicine and Reconstructive Surgery, Cleveland Clinic Foundation, April 2002. 24. “Female sexual dysfunction.” National Urology Resident Preceptorship Program in Female Pelvic Medicine and Reconstructive Surgery, Cleveland Clinic Foundation, April 2002. 25. “Stress urinary incontinence and overactive bladder: what’s new in 2002? New Perspectives in Clinical Medicine UT Southwestern CME event, Las Colinas, TX, May 11-12,2002. 26. “Bladder outlet obstruction in women: incidence and implications.” Texas Urological Society annual meeting, Tim Boone course director, San Antonio, TX June, 2002. 27. “Urinary incontinence and overactive bladder: diagnosis and treatment strategies.” CME event for Texas Academy of family physicians, Houston, TX October 2002. 28. “Female Pelvic Anatomy.” Sling-a-thon: Dallas summit on vaginal sling procedures, November 2002.

Last Revised: April 9, 2015

29. “When a good plan goes wrong: treatment options for sling failures.” Sling-athon: Dallas summit on vaginal sling procedures, November 2002. 30. “Neurogenic Detrusor Overactivity.” Paul Peters Day Urology Symposium, Dallas, TX January 2003. 31. “Overactive Bladder in the Male Patient.” The Public Health Implications of Urogenital Disease: A Focus on Overactive Bladder. Office of Women’s Health of US Department of Health and Human Services, January 2003. 32. “Urologic issues facing patients with Multiple Sclerosis.” Denton Count MS Society, March 2003. 33. “Changes in urinary bladder function and detrusor smooth muscle myocyte gene expression following spinal cord injury in a mouse model". Invited lecturer at 13th Annual McGill Urology Research Day, McGill University, April 2003. 34. “Stress Urinary Incontinence: Medical and surgical options in 2003” Women’s Healthcare Forum, Dallas, TX, September 2003. 35. “Neurourology Part 1: The basics and beyond” Department of Physical Medicine and Rehabilitation Grand Rounds. January 2004. 36. “Update on neurovesical dysfunction in Movement Disorders,” Society for Urodynamics and Female Urology annual meeting, Phoenix AZ, February 2004. 37. “Urodynamics and the Neurogenic Bladder,” Society of Urologic Nurses and Associates Annual Symposium: Disorders of the Bladder, Bowel, and Pelvic Floor, Chicago, IL, March 2004. 38. “Parkinson’s disease and Multiple Sclerosis: genitourinary dysfunction,” Neurourology: AUA/SBUR Summer Research Conference, Reston, Virginia, August 2004. 39. “Outcome measures for urinary incontinence,” Society for Urodynamics and Female Urology Annual Meeting, Orlando FL, February 2005. 40. “Minimally invasive treatments for neurogenic bladder,” American Spinal Cord Injury Association Annual Meeting, Dallas TX, May 2005. 41. “Questionnaires for the evaluation of LUTS in women: research versus reality,” International Continence Society Meeting, Montreal Canada, August 2005. 42. “Effective Treatment of Men with OAB: Shifting the Paradigm,” CME course at South Central section Meeting of the AUA, September 16, 2005. 43. “Outcome Measures for Urinary Incontinence: Future Trends,” Society of Urodynamics and Female Urology Annual Meeting, Grand Bahama Island, February 2006.

Last Revised: April 9, 2015

44. “Urethral Imaging,” Society of Urodynamics and Female Urology Meeting at AUA, Atlanta GA, May 2006. 45. “Clinical Manifestations of the Diabetic Neurogenic Bladder,” NIDDK Symposium Bladder Complications of Diabetes and Obesity, Atlanta GA, May 2006. 46. “Role of the Urologist in Prolapse Management,” Plenary Panel Member AUA, Atlanta GA, May 2006. 47. “Role of anti-muscarinics in the management of men with lower urinary tract symptoms: Redefining the paradigm.” Invited speaker at the Meeting of the Texas Physicians Assistant Society. October, 2006. 48. “Practical evaluation of post-prostatectomy incontinence,” University of Toronto Urology Update 2006, Course Director Sender Hershorn, November 2006. 49. “Evaluation and Treatment of Bladder Outlet Obstruction in Women,” University of Toronto Urology Update 2006, Course Director Sender Hershorn, November 2006. 50. “Emerging options in the treatment of Overactive Bladder” CME symposium, Houston TX, October 2007. 51. “Use of mesh in vaginal approach to pelvic organ prolapse,” Paul C. Peters Symposium, Irving TX January 2008. 52. “State of the art: Botulinum toxin for overactive bladder,” Paul C. Peters Symposium, Irving TX January 2008. 53. “Managing the neurogenic bladder in multiple sclerosis,” Visiting Professor, University of Iowa. October 2008. 54. “Bladder and Sexual Health in Spinal Cord Injury,” Visiting Professor, University of Iowa, October 2008. 55. “Incontinence in Multiple Sclerosis and Parkinson’s Disease.” Research Summit, National Institute of Digestive Diseases and Diabetes, January 2009. 56. “Urodynamics in the evaluation of stress incontinence from the SISTEr trial: Evidence for widespread application.” Plenary debate at SUFU meeting, February 2009. 57. “Urodynamics prior to treatment for SUI: What is the evidence?” Visiting Professor, Vanderbilt University, April 2009.

.

58. “Stress Incontinence: Is the Latest Really the Greatest?” Visiting Professor, Louisiana Urological Society Meeting, April 2009. .

Last Revised: April 9, 2015

59. “Neurourology Update: Managing the Bladder and Sexual Health in MS and SCI.” Visiting Professor, Louisiana Urological Society Meeting, April 2009. . 60. Moderator for Plenary Session at American Urological Association, “Neurogenic Bladder,” April 2009.

.

61. Visiting Professor, Washington University Department of Urology, December 3-4, 2009. 62. What’s new in OAB applications: Scatter shooting with botulinum toxin in 2010. Plenary lecture at Society for Urodynamics and Female Urology Meeting, February 2010. 63. “Bladder dysfunction in neurological disease.” Podium presentation at Rare Neuroimmunological Symposium” September 2010, Dallas TX. 64. Signing the right contract: what can you do to protect yourself. Podium presentation at American Urogynecology Meeting, Long Beach CA, September 2010. 65. Moderator: Office-based treatments for SUI. Plenary session at American Urological Association Meeting, May 2011. 66. Participant: “Moderator: Urodynamics: Lessons Learned from the Urinary Incontinence Treatment Network Studies” “Interstitial Cystitis Update”. 18th Annual Paul C. Peters Urology Symposium, Dallas, TX, January 27 – 29, 2012. 67. Visiting Professor, “The Edward McGuire Visiting Professor in Neurourology”, University of Michigan, February 4-5, 2012. Urodynamics: Lessons Learned from the Urinary Incontinence Treatment Network Studies” and “Evaluation of the Patient with Neurogenic Bladder: What an Analysis of the Literature Truly Supports.” 68. Visiting Professor, “The Bunts-Hackler Visiting Professor in Urology”, Virginia Commonwealth University, March 23, 2012. Urinary Incontinence Where are we now, Where have we been: A decade of learning in the UITN.” 69. History of Pelvic Prolapse Surgery: Where are we now, where have we been? Plenary presentation, SUFU meeting at American Urological Association Meeting, May 2012. 70. Update of LUTS in Parkinson’s Disease. Parkinson Association of Dallas. June 2012. 71. Debate – Mini-slings: are results reliable? Con. XII Paulista Congress of Urology. Sao Paulo Brazil, September 8, 2012. .

Last Revised: April 9, 2015

72. Debate - Urodynamics: are they mandatory before SUI surgery? Pro. XII Paulista Congress of Urology, Sao Paulo, Brazil, September 8, 2012. 73. Evaluation of urinary incontinence and the Urodynamics Guidelines – an Update. Visiting Professor at UCSD Postgraduate Course in Urology. March 22, 2013. 74. Update on Randomized Surgical Trials in Urinary Incontinence: Over a Decade of Learning in the Urinary Incontinence Treatment Network. Visiting Professor at Johns Hopkins Annual Howard Kelly Lectureship in Pelvic Reconstructive Surgery. April 4, 2013. 75. How well do urodynamics define the underlying mechanisms responsible for lower urinary tract symptoms? Plenary presentation, SUFU meeting at American Urological Association Meeting, May 2013. 76. Urinary Incontinence – Where Are We Now, Where Have We Been: A Decade and Beyond of Learning in the UITN. The 50th Harry M. Spence Visiting Professor Conference. May 22-23, 2013. 77. Invited Speaker, “Onabotulinumtoxin A (Botox) Use in Urology: Update on Indications, Efficacy and Safety”, Wednesday, September 18. 92nd Annual Meeting of the South Central Section of the AUA, September 18-21, 2013, Chicago, IL. 78. “Overactive Bladder & Painful Bladder Disorders”. Pelvic Floor Disorders Symposium: Update on the Evaluation & Treatment of Urinary Incontinence, Pelvic Organ Prolapse, Fecal Incontinence, Pelvic Pain & Pelvic Floor Dysfunction. Saturday, September 21, 2013, Dallas, TX. 79. “Treatment options for patients with refractory neurogenic bladder conditions.” Meeting of the Transverse Myelitis Association. October 2013. Dallas. 80. Participant Advances in Urologic Reconstruction, Female Urology – “Urodynamics Guidelines”, Breakout Session “Contemporary Management of Overactive Bladder” Friday, January 31 – Sunday, February 2, 2014, 20th Annual Paul C. Peters Urology Symposium, Dallas, TX. 81. Evaluation & management of urinary incontinence in female patients after radiation. The Society of Urodynamics Female Pelvic Medicine and Urogenital Reconstruction session during the AUA meeting, Orlando, Florida, May 2014. 82. “Overactive Bladder”. Pelvic Floor Disorders Symposium: Update on the Evaluation & Treatment of Urinary Incontinence, Pelvic Organ Prolapse, Fecal Incontinence, Pelvic Pain & Pelvic Floor Dysfunction. September, 2014, Dallas, TX 83. Overactive Bladder and Insights on Logistics and Efficiencies. Maine Urological Association’s 2015 Annual CME Winter Meeting, Carrabassett Valley, Maine, February 2015.

Last Revised: April 9, 2015

84. Urinary Incontinence - Where are we now, and where have we been? A Decade and Beyond of Learnng in the UITN. Maine Urological Association’s 2015 Annual CME Winter Meeting, Carrabassett Valley, Maine, February 2015. 85. Panel Moderator, Current trends in management of SUI. Society of Urodynamics, Female Pelvic Medicine and Urogenital Reconstruction Annual Meeting, Scottsdale, AZ, February 2015. 86. Update on Clinical Cooperative Trials in Urinary Incontinence, University of Toledo. Speaker, Northeast Ohio Urological Society Meeting, March 2015.

REFERENCES

Furnished upon request.

Last Revised: April 9, 2015